Home
menu Home

Program - Day 1 (Aug. 31, 2024)

Click the Button to check time for each country where you are located.




Room A

Time Program Chair / Speaker
09:25-09:30 Opening Remark CHOE Yong Beom
(President of the 2nd ASP 2024 Seoul)
09:30-09:35 Congratulatory Message OZAWA Akira
(President of ASP)
09:35-09:40 KANG Hoon
(President of KDA)
09:40-09:55 Meeting report from ASP
09:40-09:50 Reflecting on Achievements: A Comprehensive Review of the 1st ASP MABUCHI Tomotaka
(Japan)
09:50-09:55 Setting New Horizons: Visions and Preparations for ASP 2024 KIM Byung Soo
(Secretary General of the 2nd ASP 2024 Seoul)
09:55-10:15 Plenary lecture 1: The Past, Present and Future Perspective of ASP  
 
TBD YOUN Jai Il
(Korea)
10:15-11:25 The Role of Dermatologists in Psoriatic Arthritis (Panel Discussion 1)  
 
 
10:15-10:25 Management of Treating Psoriatic Arthritis  
10:25-10:35 Clinical Settings and Experiences in Japan  
10:35-10:45 Clinical Settings and Experiences in Vietnam  
10:45-10:55 Rheumatologist's Perspective  
10:55-11:25 Discussion  
11:25-11:35 Group Photo
11:35-12:55 Luncheon Symposium #1 (Jansen)  
Guiding New Perspectives in Psoriasis: Can We Modify Psoriasis Disease Course? SCHAKEL Knut
(Germany)
12:55-13:25 Invited Lecutre #1  
Recent Landscape in Psoriasis Management MORITA Akimichi
(Japan)
13:25-13:55 Invited Lecutre #2  
From Bench to Bedside: The Future Path of Psoriasis Treatment Development CHO Raymond J
(USD)
13:55-14:25 Invited Lecutre #3  
Asia Pacific Consensus Recommendations for the Management of Generalized Pustular Psoriasis CHOON Siew Eng
(Malaysia)
14:25-15:05 Coffee break and Poster Rounding
15:05-16:15 Comparative Landscapes of Psoriasis across Asia- Epidemiology and Healthcare Systems
(Panel Discussion 2)		  
15:05-15:15 Korea KIM Jeong Eun
(Korea)
15:15-15:25 Japan YAMAGUCHI Yukie
(Japan)
15:25-15:35 Philippines GUEVARA Bryan
(Philippines)
15:35-15:45 Malaysia AZURA Mohd Affandi
(Malaysia)
15:45-16:15 Panel Discussion  
 
 
 
16:15-17:25 Exploring Psoriasis Treatment Goals and Modalities in Asian Countries
(Panel Discussion 3)		  
16:15-16:25 Korea BANG Chul Hwan
(Korea)
16:25-16:35 China CHEN Xi-Bei
(China)
16:35-16:45 Singapore THENG Colin
(Singapore)
16:45-16:55 Indonesia WAHYUDI Danang Tri
(Indonesia)
16:55-17:25 Panel Discussion  
 
 
 

Room B

Time Program Chair / Speaker
10:15-11:25 Practical Tips in Treating Psoriasis Patients  
 
10:15-10:35 Patient Education KIM Yoon-Seob
(Korea)
10:35-10:55 Interdepartment Consultation JUNG Hye Jung
(Korea)
10:55-11:15 Frequently Asked Questions from Patients KIM Hei Sung
(Korea)
11:15-11:25 Q & A and Discussion  
11:25-11:35 Group Photo
11:35-12:55 Luncheon Symposium #2 (BMS)  
Oral TYK2 inhibitor Deucravacitinib: Long-term efficacy and safety profile ARMSTRONG April Wang
(US)
12:55-13:40 Sponsor Lecture by Boehringer Ingelheim  
Targeting IL-36 in GPP: Treatment Goals & Current Learnings
(Japanese Real World Cases)		 TADA Yayoi
(Japan)
13:40-14:25 Sponsor Lecture by UCB  
The Future of Psoriasis Management with Advanced MOA  
14:25-15:05 Coffee break and Poster Rounding
15:05-16:05 The Next Era of Psoriasis Treatment  
15:05-15:25 Biosimilars for Psoriasis and Psoriatic Arthritis PARK Eun Joo
(Korea)
15:25-15:45 Stem Cell Therapy for Psoriasis KUANG Yehong
(China)
15:45-16:05 Upcoming Therapeutics in Psoriasis JO Seong-Jin
(Korea)
16:05-17:25 Research Session  
16:05-16:25 MyD88-DC-CXCL16 axis Results Neutrophil Activation to Elicit Inflammatory Response in Pustular Psoriasis SHI Yuling
(China)
16:25-16:45 Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin IMAFUKU Shinichi
(Japan)
16:45-17:05 The Role of Xenobiotics in Psoriasis CHUNG Bo Young
(Korea)
17:05-17:25 Semaphorin 4A and Psoriasis FUJIMOTO Manabu
(Japan)
Go to Top